Scarica l'app Stockscreener
10.01
1.01%
0.10
Dopo l'orario di chiusura:
10.07
0.06
+0.60%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CAPR Giù?
Forum
Previsione
Frazionamento azionario
Capricor Therapeutics Inc Borsa (CAPR) Ultime notizie
CAPR Stock Sinks As Investors Brace For Imminent FDA Call On Deramiocel - Stocktwits
Capricor Therapeutics (NASDAQ:CAPR) Healthcare Strategy Focus - Kalkine Media
Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Activist Investor Sounds Alarm on Capricor’s Cash Burn - TradingView
/C O R R E C T I O N — Kessler Topaz Meltzer & Check, LLP/ - Morningstar
Activist Investor Kaos Capital Demands Board Overhaul at Capricor Ahead of FDA Decision on DMD Therapy - finance.biggo.com
INVESTOR DEADLINE: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Substantial Losses Have Opportunity to Lead Capricor Class Action Lawsuit Before September 28, 2026 Deadline - PR Newswire
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law - lincolnjournal.com
Capricor Stock Faces Securities-Fraud Case as FDA Review Stays Open - TechStock²
Kaos Capital Pushes for Strategic Board Meeting at Capricor Ther - GuruFocus
Kaos Capital pushes for board changes at Capricor Therapeutics - Investing.com
Kaos Capital pushes for board changes at Capricor Therapeutics By Investing.com - Investing.com Canada
Capricor shareholder cites ~$80.2M cash drop and seeks spending cuts - Stock Titan
Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders - Yahoo Finance
Duchenne Cell Therapy Shifts Its Target from the Heart to Arm Function as Decision Date Slips - Medical Daily
Shareholder pressures Capricor; Lilly dives deeper into vaccines - Yahoo Finance
Capricor (CAPR) Q2 2026 Earnings Call Transcript - AOL.com
Capricor Draws Investor Attention As Shareholder Kaos Capital Pushes For Board Shakeup Ahead Of Key FDA Decision On DMD Therapy - Stocktwits
Capricor (CAPR) Q2 2026 Earnings Call Transcript - The Motley Fool
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm to Learn About Their Legal Rights - The Globe and Mail
Deadline Alert: Capricor Therapeutics, Inc. (CAPR) - GlobeNewswire
Capricor Therapeutics (CAPR) Faces Valuation Challenges Ahead of FDA Decision - GuruFocus
Capricor Therapeutics, Inc. Investors Have Opportunity to - GlobeNewswire
CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics Securities LawsuitContact SueWallSt - Morningstar
Capricor Therapeutics (CAPR) Faces Market Pressure Amid FDA Conc - GuruFocus
Capricor Therapeutics Shareholder Alert: ClaimsFiler - GlobeNewswire
Capricor slips on potential Deramiocel rejection (CAPR:NASDAQ) - Seeking Alpha
CAPR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesCAPR - PR Newswire
Piper Sandler Downgrades Capricor Therapeutics, Cuts Target to $2 - scanx.trade
CAPRICOR THERAPEUTICS, INC. (CAPR) SHAREHOLDER ALERT - GlobeNewswire
$Capricor Therapeutics (CAPR.US)$ FDA APPROVAL 2026-08-22 in two days get ready!!! - Moomoo
CAPR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (N - The National Law Review
Capricor (CAPR) Closed 58% Higher on an FDA Lifeline. Is Approval Really Back on Track? - Yahoo Finance
Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026 - Barchart.com
Capricor Therapeutics (CAPR): Millennium stake slips under 5% - Stock Titan
ROSEN, A LEADING NATIONAL FIRM, Encourages Capricor - GlobeNewswire
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - TMX Newsfile
CAPR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026 - TMX Newsfile
Bronstein, Gewirtz & Grossman LLC Urges Capricor - GlobeNewswire
INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit: Investors Face September 28, 2026, Deadline - NewMediaWire
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar
CAPR Investor Reminder: Capricor Therapeutics Securities - GlobeNewswire
Capricor Therapeutics, Inc. Notice of September 28, 2026 - GlobeNewswire
INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NewMediaWire
Robbins LLP Urges CAPR Stockholders to Contact the Firm for Information About the Class Action Against Capricor Therapeutics, Inc. - WBOC TV
CAPR INVESTOR REMINDER: Capricor Therapeutics, Inc. Investors Have Until September 28, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role - lincolnjournal.com
Kaplan Fox & Kilsheimer LLP Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before September 28, 2026 - Barchart.com
All Eyes On Capricor Therapeutics Ahead Of Crucial Hearing On DMD Therapy Agreement – CAPR Stock Jumps 6% - Stocktwits
Lost Money on Capricor Therapeutics, Inc. (CAPR)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - Morningstar
CAPR Stock Sinks After-Hours: Capricor Launches Legal Fight Over DMD Therapy Rollout Ahead Of FDA Review - Stocktwits
Kaplan Fox Class Action Reminder: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Lead Plaintiff Deadline is September 28, 2026 - The Globe and Mail
CAPR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026 - TMX Newsfile
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (CAPR) - TMX Newsfile
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces - GlobeNewswire
Q3 EPS Estimate for Capricor Therapeutics Cut by Analyst - MarketBeat
Capricor Therapeutics (CAPR) Could Be 89% Undervalued Following Deramiocel And Loss Concerns - Sahm
CAPR Stock News: Capricor Therapeutics Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 64% Stock Drop - PR Newswire
CAPR Stock Alert: Capricor Therapeutics, Inc. (CAPR) Reports Q2 Earnings Amid Ongoing Securities Class Action LawsuitHagens Berman - PR Newswire
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Receives Average Rating of "Hold" from Brokerages - MarketBeat
CAPR Stock Alert: Capricor Therapeutics, Inc. (CAPR) Reports Q2 E - The National Law Review
CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CAPR Stock Alert: Capricor Therapeutics, Inc. (CAPR) - GlobeNewswire
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) is September 28, 2026 - The Globe and Mail
0.33%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):